AbbVie

Annual Revenue Estimate: $10bn+

AUM: $25bn-$50bn

Email Convention: NA

Overview

Overall Ranking (80%)

The Overall Ranking is a score from 1 star (very bad) to 5 stars (excellent) generated based on the Company Reviews of current and former employees at this company, taking everything into account.

The number you see in the middle of the donut pie chart is the simple average of these scores. If you hover over the various sections of the donut, you will see the % breakdown of each score given.

The percentile score in the title is calculated across the entire Company Database and uses an adjusted score based on Bayesian Estimates (to account for companies that have few reviews). Simply put, as a company gets more reviews, the confidence of a "true score" increases so it is pulled closer to its simple average and away from the average of the entire dataset.

The Overall Ranking is generated based on the Company Reviews.

3.8
  • 5 Stars
  • 4 Stars
  • 3 Stars
  • 2 Stars
  • 1 Star

Company Details

AbbVie came from Abbott but hopes to have a life of its own. The pharmaceutical research company was spun off from its former parent, health care products maker Abbott Labs, in early 2013. AbbVie has seven facilities making products that are available in more than 170 countries. Its key drugs include arthritis and Crohn's disease treatment Humira; TriCor, Trilipix, Simcor, and Niaspan for high cholesterol; HIV drugs Kaletra and Norvir; and low testosterone treatment AndroGel, among others. Humira, which is best known as a rheumatoid arthritis drug, accounts for half of AbbVie's sales. With its main product's patent protection expiring in 2016, the R&D company is hard at work looking for the next big thing.

Locations

Location

Headquarters

See in Google Maps

1 N. Waukegan Rd., North Chicago, IL, 60064, United States

(847) 932-7900

.